NRG-CC009 for Brain Mets from SCLC with Dr. Vinai Gondi

from The NRG Oncology Podcast · host NRG Oncology

NRG Oncology Podcast co-hosts talk with Dr. Vinai Gondi, the Principal Investigator of the NRG-CC009 phase III clinical study assessing stereotactic radiosurgery (SRS) versus hippocampal-avoidant whole brain radiotherapy (HA-WBRT) for patients who have brain metastases (or cancer that has spread to the brain) from their small cell lung cancer (SCLC).

Episode metadata supplied by the publisher feed · Published May 2, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

NRG-CC009 for Brain Mets from SCLC with Dr. Vinai Gondi

0:00 33:13

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The NRG Oncology Podcast?

This episode is 33 minutes long.

When was this The NRG Oncology Podcast episode published?

This episode was published on May 2, 2025.

Can I download this The NRG Oncology Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!